Business ProfileforMallinckrodt Group
Current Alerts For This Business
On August 2, 2022, Colorado Attorney General, Phil Weiser, announced Mallinckrodt will pay Colorado $18 million for its role in fueling the opioid epidemic.
Mallinckrodt was one of the largest pharmaceutical manufacturers in the U.S. and manufactured a generic version of the opioid drug oxycodone. A U.S. Drug Enforcement Agency database shows that from 2006 to 2012, one of Mallinckrodt’s subsidiary companies distributed 28.9 billion generic opioid pills in the U.S.—more than 80 pills for each person in the country.
In addition to paying to settle the claims against it, Mallinckrodt will be subject to stringent, legally enforceable terms that will prevent the company from marketing opioids and ensure that systems are in place to prevent misrepresentation and misuse. Mallinckrodt is also required to fund a document repository with the company’s records to make public its role in fueling the opioid epidemic. To date, more than one million of the company’s documents have been released.
Additional business information
On June 24, 2022, all 50 states, Washington D.C, Puerto Rico and the federal government settled fraud allegations against Mallinckrodt ARD, LLC.
The total value of the settlement is $233,707,865.18, plus interest, to be paid over a seven year period.
Mallinckrodt violated the Federal False Claims Act by underpaying Medicaid rebates due for its drug, H.P. Acthar Gel from January 1, 2013 – June 30, 2020.
Under the Medicaid Drug Rebate Program, when a manufacturer increases the price of a drug faster than the rate of inflation, it must pay the Medicaid program a per-unit rebate of the difference between the drug’s current price and the price of the drug if its price had gone up at the general rate of inflation since 1990 or the year the drug first came to market, whichever is later.
At-a-glance
Related Categories
Business Details
This is a multi-location business.
- Headquarters
- 675 James S McDonnell Blvd, Hazelwood, MO 63042-2301
- BBB File Opened:
- 2/14/1995
- Years in Business:
- 157
- Business Started:
- 1/1/1867
- Business Started Locally:
- 1/1/1867
- Business Incorporated:
- 2/28/1994
- Type of Entity:
- Corporation
- Alternate Business Name
- Tyco Healthcare
- Tyco Mallinckrodt Inc
- Business Management
- Sarah Kramer, Manager of Corporate Communications
- Mr. Raymond F Bentele, Manager
- Contact Information
Customer Contact
- Sarah Kramer, Manager of Corporate Communications
- Additional Contact Information
Fax Numbers
- (314) 654-5381Primary Fax
- (314) 854-5530Other Fax
Phone Numbers
- (314) 895-2000Other Phone
- (314) 854-5200Other Phone
- (314) 654-5381
Customer Complaints
0 Customer Complaints
Need to file a complaint? BBB is here to help. We'll guide you through the process. How BBB Processes Complaints and Reviews
File a ComplaintBBB Business Profiles may not be reproduced for sales or promotional purposes.
BBB Business Profiles are provided solely to assist you in exercising your own best judgment. BBB asks third parties who publish complaints, reviews and/or responses on this website to affirm that the information provided is accurate. However, BBB does not verify the accuracy of information provided by third parties, and does not guarantee the accuracy of any information in Business Profiles.
When considering complaint information, please take into account the company's size and volume of transactions, and understand that the nature of complaints and a firm's responses to them are often more important than the number of complaints.
BBB Business Profiles generally cover a three-year reporting period. BBB Business Profiles are subject to change at any time. If you choose to do business with this business, please let the business know that you contacted BBB for a BBB Business Profile.
As a matter of policy, BBB does not endorse any product, service or business. Businesses are under no obligation to seek BBB accreditation, and some businesses are not accredited because they have not sought BBB accreditation.